Causes and Diagnostic Approach to Hyponatremia and Hypokalemia

Hyponatremia – General Principles

• Hyponatremia arises from three primary mechanisms—volume depletion, inappropriate water retention (e.g., SIAD), or dilutional states; classification by volume status and urine sodium is essential to guide therapy. 1, 2

Hyponatremia – Volume‑Based Classification

Hypovolemic Hyponatremia (Sodium + Water Loss)

• Renal losses (urine Na > 40 mEq/L) are most often due to diuretic use, but may also result from cerebral salt wasting, adrenal insufficiency, or salt‑wasting nephropathy. 1, 2
• Extrarenal losses (urine Na < 30 mEq/L) include vomiting, diarrhea, excessive laxative use, gastrointestinal bleeding, and third‑space fluid sequestration. 1, 2

Euvolemic Hyponatremia (Water Retention)

• Syndrome of inappropriate antidiuresis (SIAD) is characterized by urine osmolality > 100 mOsm/kg, urine sodium > 40 mEq/L, low serum uric acid (< 4 mg/dL), and clinical euvolemia. 2
• Hypothyroidism can present as euvolemic hyponatremia. 1, 2
• Adrenal insufficiency may manifest as either euvolemic or hypovolemic hyponatremia. 1, 2
• Primary polydipsia (excessive water intake) is another cause of euvolemic hyponatremia. 3

Hypervolemic Hyponatremia (Total Body Sodium Excess with Greater Water Excess)

• Cirrhosis with ascites: vasopressin‑mediated water retention produces dilutional hyponatremia. 1, 2
• Heart failure: reduced effective arterial volume triggers vasopressin release, leading to water retention and hyponatremia. 2
• Nephrotic syndrome can also cause hypervolemic hyponatremia. 3

Special Causes and Precipitants

• Pseudohyponatremia is a laboratory artifact caused by severe hypertriglyceridemia or paraproteinemia; serum osmolality remains normal (> 280 mOsm/L). 1, 2
• Acute infection in cirrhosis may precipitate hyponatremia; diagnostic paracentesis and cultures are recommended. 1, 2

Hypokalemia – General Principles

• Hypokalemia results from inadequate intake, transcellular shifts, or excessive losses (renal or extrarenal); diuretic use and gastrointestinal losses are the most common clinical contributors. 4

Hypokalemia – Mechanisms

Inadequate Intake

• Malnutrition, eating disorders, and prolonged fasting can lead to low potassium stores. 4

Transcellular Shifts (Potassium Moves Intracellularly)

• Insulin administration or endogenous hyperinsulinemia drives potassium into cells, lowering serum levels. 4
• β₂‑agonist therapy similarly promotes intracellular potassium shift. 4

Renal Losses (Inappropriate Urinary Potassium Excretion)

• Diuretic therapy (thiazides and loop diuretics) is the leading iatrogenic cause of renal potassium loss. 4
• Hyperaldosteronism (primary or secondary) increases renal potassium excretion. 4
• Renal tubular acidosis (types I and II) is associated with renal potassium wasting. 4

Extrarenal Losses

• Gastrointestinal losses (diarrhea, laxative abuse, vomiting, nasogastric suction) can deplete potassium. 4
• Excessive sweating contributes to potassium loss, especially in hot environments or during intense exercise. 4

Combined Hyponatremia and Hypokalemia

• In patients with cirrhosis receiving diuretics, RAAS activation produces hypervolemic hyponatremia while the diuretic effect induces hypokalemia. 1, 2

Critical Diagnostic Pitfalls

• Misclassifying cerebral salt wasting as SIAD leads to inappropriate fluid restriction; volume expansion is required and failure increases cerebral infarction risk from 21 % to 81 %. 3
• Physical examination alone is unreliable for assessing volume status (sensitivity ≈ 41 %); urine sodium, urine osmolality, and serum osmolality must be obtained for accurate evaluation. 3, 5
• In cirrhosis, new‑onset hyponatremia should prompt evaluation for infection, as acute inflammation frequently precipitates the electrolyte disturbance. 1, 2

Evaluation of Hyponatremia in Patients with Hypertension

Serum Electrolyte Assessment

• Serum potassium is frequently low in conjunction with hypotonic hyponatremia; correcting potassium to the laboratory reference range is required before the hyponatremia work‑up can be accurately interpreted. 6

Screening for Primary Aldosteronism

• In hypertensive individuals—especially those who also have hypokalemia—primary aldosteronism should be screened by measuring plasma renin activity (or direct renin concentration) together with plasma aldosterone concentration, because this endocrine disorder can coexist with hyponatremia. 6

Interpretation of Aldosterone‑Renin Ratio (ARR)

• A positive screen for primary aldosteronism is defined by a suppressed renin level and an elevated aldosterone‑to‑renin ratio (ARR > 20 when aldosterone is measured by immunoassay); hypokalemia must be corrected and any interfering medications managed before interpreting the ratio. 6

Medication Effects on ARR Testing

• β‑adrenergic blockers and centrally acting α₂‑agonists (e.g., clonidine, α‑methyldopa) can lower renin, producing false‑positive ARR results; therefore, the test should be repeated after a safe 2‑week withdrawal of these agents when feasible. 6

Additional Hormonal and Metabolic Tests

• A comprehensive hyponatremia evaluation should also include serum uric acid, thyroid‑stimulating hormone (TSH), and a morning cortisol measurement to identify other metabolic or endocrine contributors. 6

Psychogenic Polydipsia: Definition, Epidemiology, and Evidence‑Based Management

Definition & Epidemiology

• Psychogenic polydipsia (also termed primary polydipsia or compulsive water drinking) is a disorder of compulsive excess fluid intake that leads to dilutional (euvolemic) hyponatraemia, and it is especially common among individuals with schizophrenia. 7

Acute Management

• In patients presenting with symptomatic hyponatraemia or serum sodium < 120 mmol/L, immediate hospitalisation is required.
• Discontinuation or reduction of diuretics and laxatives that may aggravate hyponatraemia is recommended. 8
• Sodium should be corrected slowly, not exceeding an increase of 8–10 mmol/L in any 24‑hour period, to avoid osmotic demyelination syndrome. 9

Outpatient & Long‑Term Management

• For asymptomatic individuals, restricting fluid intake to approximately 1–1.5 L per day is the cornerstone of outpatient therapy. [8][9]
• Routine screening for acute infection should be performed in any psychiatric patient who develops new or worsening hyponatraemia, as infection can precipitate the electrolyte disturbance. 8

Strength of evidence: The cited sources provide expert consensus and clinical guideline recommendations; specific grading (e.g., Class I, Level A) was not reported in the references.

Cerebral Salt Wasting as a Cause of Hypovolemic Hyponatremia

Hypovolemic Hyponatremia – Renal Sodium Losses

• In patients with hypovolemic hyponatremia due to renal sodium loss (urine sodium > 40 mEq/L), cerebral salt wasting is a recognized etiology, particularly in individuals undergoing neurosurgical procedures or those with subarachnoid hemorrhage, where excessive natriuresis leads to a predominance of sodium loss over water loss. 10